Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
Dan Rosmarin, Ian D. Tomlinson, Claire Palles(University of Oxford), Zdeněk Kleibl, Rohini Sharma(Hammersmith Hospital), Alain Morel(Centre Hospitalier Universitaire de Montpellier), Howard L. McLeod(Unknown), Henrik Enghusen, Benjamin Lacas, Marie-Christine Etienne-Grimaldi, Daniel J. Sargent(National Institute of Agricultural Botany), Claire Scudder, Jesús García‐Foncillas(Hospital Universitario Fundación Jiménez Díaz), Eva Martinez‐Balibrea, David Kerr(University of Oxford), Anna González‐Neira(Spanish National Cancer Research Centre), Angela Jones(Vanderbilt University Medical Center), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), Patrick Julier, Valérie Boige(Inserm), Jean‐Pierre Pignon(Inserm), Ulrich M. Zanger(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Sharon Love(Nuffield Orthopaedic Centre), Michael Braun(Peter MacCallum Cancer Centre), Hans Garmo(Uppsala University), Bengt Glimelius(Uppsala University), Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Michel Seymour(University of Leeds), Erin Green, David N. Church(Centre for Human Genetics), Milena Gusella, Elaine Johnstone(University of Oxford), Thierry Lecomte(Université Paris Cité), Enric Domingo(Universitätsklinikum Erlangen), Nuria Ribelles(Instituto de Investigación Biomédica de Málaga), Pierre Laurent‐Puig(Inserm), G. Milano(Centre Antoine Lacassagne), Haitao Wang(Wuhan University), Miguel Martín(Hospital General Universitario Gregorio Marañón), Søren Astrup Jensen, Shoaib Afzal, Rachel Midgley(University of Oxford), Mia Wadelius(Uppsala University)
Cited by 261
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k